Effect of 5-HT, receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice

被引：0
|
作者：
Popik, P
Kos, T
Pietraszek, M
Schäfer, D
Danysz, W
Dravolina, O
Blokhina, E
Galankin, T
Bespalov, AY
机构：
[1] Polish Acad Sci, Lab Behav Neurosci, Dept Biochem, Inst Pharmacol, Krakow, Poland
[2] Merz Pharmaceut, Behav Pharmacol, Frankfurt, Germany
[3] Pavlov Med Univ, Lab Behav Pharmacol, Inst Pharmacol, St Petersburg, Russia
来源：
BEHAVIOURAL PHARMACOLOGY | 2005年 / 16卷
关键词：
D O I：
10.1097/00008877-200509001-00280
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
下载
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [21] 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat
    Kankaanpää, A
    Meririnne, E
    Seppälä, T
    PSYCHOPHARMACOLOGY, 2002, 159 (04) : 341 - 350
  • [22] CHARACTERIZATION OF THE 5-HT RECEPTOR SUBTYPES INVOLVED IN THE MOTOR BEHAVIORS PRODUCED BY INTRATHECAL ADMINISTRATION OF 5-HT AGONISTS IN RATS
    FONE, KCF
    ROBINSON, AJ
    MARSDEN, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1547 - 1555
  • [23] EFFECT OF PYRIDOSTIGMINE ON PHARMACOKINETICS OF THE 5-HT(3) RECEPTOR ANTAGONIST ONDANSETRON
    CAPACIO, BR
    BYERS, CE
    MATTHEWS, RL
    FASEB JOURNAL, 1993, 7 (04): : A699 - A699
  • [24] PHARMACOKINETICS (PK) OF A NEW SEROTONIN 5-HT(3) RECEPTOR ANTAGONIST, MDL-73,147EF
    BOXENBAUM, H
    GILLESPIE, T
    HECK, K
    HAHNE, WF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 131 - 131
  • [25] THE SIMILARITY OF PLATELET 5-HT INDUCED AGGREGATION RECEPTOR TO 5-HT RECEPTOR IN THE CNS
    GAVISH, M
    GOLDSTEIN, S
    YOUDIM, MBH
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1981, 17 (11): : 1099 - 1099
  • [26] Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction
    Galzin, AM
    Delahaye, M
    Hoornaert, C
    McCort, G
    O'Connor, SE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 404 (03) : 361 - 368
  • [27] Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice
    Yamada, J
    Sugimoto, Y
    Ohkura, M
    Inoue, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (10) : 1195 - 1197
  • [28] Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist
    Dawson, LA
    Nguyen, HQ
    Li, P
    BRAIN RESEARCH BULLETIN, 2003, 59 (06) : 513 - 521
  • [29] CHARACTERIZATION OF THE 5-HT(2) RECEPTOR ANTAGONIST MDL 100907 AS A PUTATIVE ATYPICAL ANTIPSYCHOTIC - BEHAVIORAL, ELECTROPHYSIOLOGICAL AND NEUROCHEMICAL STUDIES
    SORENSEN, SM
    KEHNE, JH
    FADAYEL, GM
    HUMPHREYS, TM
    KETTELER, HJ
    SULLIVAN, CK
    TAYLOR, VL
    SCHMIDT, CJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (02): : 684 - 691
  • [30] The 5-HT3 receptor antagonist, MDL 72222, dose-dependently potentiates morphine-induced immediate-early gene expression in the rat caudate putamen
    Frankel, PS
    Harlan, RE
    Garcia, MM
    BRAIN RESEARCH, 1998, 814 (1-2) : 186 - 193
12345